Avacta Group (LON:AVCT) Stock Crosses Below 200-Day Moving Average – What’s Next?

Avacta Group Plc (LON:AVCT)’s share price passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 59.32 and traded as low as GBX 54. Avacta Group shares last traded at GBX 54.55, with a volume of 1,327,316 shares.

Wall Street Analysts Forecast Growth

Separately, Peel Hunt reaffirmed a “buy” rating and set a GBX 99 price objective on shares of Avacta Group in a research note on Monday, October 13th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of GBX 99.

Avacta Group Price Performance

The company has a quick ratio of 4.96, a current ratio of 1.29 and a debt-to-equity ratio of 52.53. The firm has a market capitalization of £238.51 million, a PE ratio of -3.13 and a beta of 1.12. The stock has a 50-day moving average price of GBX 67.92 and a 200 day moving average price of GBX 59.43.

About Avacta Group

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).